ccl5 levels (R&D Systems)
Structured Review
Ccl5 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 105 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccl5+levels/Human+CCL5%2FRANTES+DuoSet+ELISA/pm40992060-117-1-15
Average 94 stars, based on 105 article reviews
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis Article Snippet: .. Article Title: High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury. Article Snippet: For the use of a specific inhibitor of HMGB1mediated astrocyte production of CCL5, astrocyte was treated with the selective RAGE inhibitor FPS-ZM1 (MCE, cat. no. HY-19370), the TLR2 inhibitor C29 (MCE, cat. no. 363600-92-4), the TLR4 inhibitor TAK242 (sigma, cat. no. 614316), the P38 inhibitor B203580 (TOCRIS, cat. no. 1202), the JNK inhibitor SP600125 (TOCRIS, cat. no. 1496), the ERK inhibitor PD98059 (TOCRIS, cat. no. 1213), or the NF-κB inhibitor SN50 (MCE, cat. no. HY-P0151) for 24 h. Cell supernatants were harvested, and cells and tissue samples were lysed in buffer containing 1% SDS, 100 mM Tris-HCl, 1 mM PMSF, and 0.1 mM β-mercaptoethanol. .. The lysates were centrifuged at 12,000×g for 15 min. Article Title: Astrocytic TGFβ signaling limits inflammation and reduces neuronal damage during CNS Toxoplasma infection Article Snippet: .. Article Title: CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis. Article Snippet: .. Article Title: High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury Article Snippet: For the use of a specific inhibitor of HMGB1-mediated astrocyte production of CCL5, astrocyte was treated with the selective RAGE inhibitor FPS-ZM1 (MCE, cat. no. HY-19370), the TLR2 inhibitor C29 (MCE, cat. no. 363600-92-4), the TLR4 inhibitor TAK-242 (sigma, cat. no. 614316), the P38 inhibitor B203580 (TOCRIS, cat. no. 1202), the JNK inhibitor SP600125 (TOCRIS, cat. no. 1496), the ERK inhibitor PD98059 (TOCRIS, cat. no. 1213), or the NF-κB inhibitor SN50 (MCE, cat. no. HY-P0151) for 24 h. Cell supernatants were harvested, and cells and tissue samples were lysed in buffer containing 1% SDS, 100 mM Tris-HCl, 1 mM PMSF, and 0.1 mM β-mercaptoethanol. .. The lysates were centrifuged at 12,000×g for 15 min. Article Title: Cancer-associated fibroblast-derived CCL5 enhanced aerobic glycolysis through upregulation of IP3R to promote breast cancer cell metastasis. Article Snippet: Background: This study aimed to investigate whether cancer-associated fibroblast (CAF)-derived chemokine C-C motif ligand 5 (CCL5) promotes breast cancer (BC) cell metastasis by enhancing aerobic glycolysis via upregu- other:Article Title: SAMD9 senses cytosolic double-stranded nucleic acids in epithelial and mesenchymal cells to induce antiviral immunity Article Snippet: Human SAMD9 Taqman primers were ordered commercially (Thermo Fisher Scientific #Hs00539471_s1). Article Title: SAMD9 senses cytosolic double-stranded nucleic acids in epithelial and mesenchymal cells to induce antiviral immunity. Article Snippet: Mouse Samd9l Taqman primers were ordered commercially (Thermo Fisher Scientific #Mm00612478_s1). |


